Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death

Saved in:

Bibliographic Details
Other Authors:	Abraham, Edward P. (Other) , Laterre, Pierre-Francois (Other) , Garg, Rekha (Other) , Levy, Howard (Other) , Talwar, Deepak (Other) , Trzaskoma, Benjamin L. (Other) , Francois, Bruno (Other) , Guy, Jeffrey S. (Other) , Brückmann, Martina (Other) , Rea-Neto, Alvaro (Other) , Rossaint, Rolf (Other) , Perrotin, Dominique (Other) , Sablotzki, Armin (Other) , Arkins, Nancy (Other) , Utterback, Barbara G. (Other) , Macias, William L. (Other)
Format:	Article (Journal)
Language:	English
Published:	2005
In:	The New England journal of medicine Year: 2005, Volume: 353, Issue: 13, Pages: 1332-1341
ISSN:	0028-4793
Online Access:
Author Notes:	Edward Abraham, M.D., Pierre-François Laterre, M.D., Rekha Garg, M.D., Howard Levy, M.D., Ph.D., Deepak Talwar, M.D., Benjamin L. Trzaskoma, M.S., Bruno François, M.D., Jeffrey S. Guy, M.D., Martina Brückmann, M.D., Álvaro Rea-Neto, M.D., Rolf Rossaint, M.D., Dominique Perrotin, M.D., Armin Sablotzki, M.D., Ph.D., Nancy Arkins, R.N., Barbara G. Utterback, M.S., M.B.A., and William L. Macias, M.D., for the Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) Study Group

Description
ISSN:	0028-4793

Similar Items